Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Siedlcach
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Siedlcach, the clinical research focus includes cardiovascular diseases, with studies centered on reducing major heart-related events in people at elevated risk. The trials are aimed at evaluating whether new treatment approaches can lower the chance of serious outcomes such as heart attack, stroke, or death from coronary disease.
- Studying adults at high cardiovascular risk without prior heart attack or stroke
- Assessing whether treatment can prevent coronary heart disease death and myocardial infarction
- Exploring ways to reduce ischemic stroke and other major arterial events
This work reflects an effort to improve prevention strategies and better protect patients who are vulnerable to serious cardiovascular events.
Nutritional and Metabolic Diseases
Research in nutritional and metabolic diseases at the Oddzial Kardiologiczny also includes patients with acute heart failure, where investigators are evaluating treatments that may help stabilize the condition and improve recovery after hospitalization. The main goal is to determine whether starting therapy during hospital care can reduce worsening heart failure and cardiovascular death.
- Focusing on acute heart failure after hospital stabilization
- Testing whether treatment can lower the risk of cardiovascular death
- Evaluating approaches to prevent worsening heart failure
These studies are designed to improve treatment effectiveness and support better outcomes for patients recovering from serious heart failure episodes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Siedlcach
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Dapagliflozin Propanediol Monohydrate on Cardiovascular Outcomes in Stabilized Acute Heart Failure Patients: A Randomized, Double-Blind, Placebo-Controlled Trial | The Brigham And Women’s Hospital Inc. | Phase I | Not Recruiting | Feb 2023 | Jun 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin Propanediol Monohydrate | 1 | Unknown | 2023-02-14 | 2023-02-14 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.